Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant

Details for Australian Patent Application No. 2005259523 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Schmelzer, Christel; Froemder, Arne

Agent Davies Collison Cave

Pub. Number AU-B-2005259523

PCT Pub. Number WO2006/002840

Priority 10 2004 032 322.4 02.07.04 DE; 10 2005 023 334.1 17.05.05 DE

Filing date 25 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 9 June 2011

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/002840 Priority application(s): WO2006/002840

9 June 2011 Application Accepted

  Published as AU-B-2005259523

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259524-Analysis method

2005259512-Thiazolinone unsubstituted quinolines